HK1091129A1 - Food for improving clinical conditions capable of lowering the concentration of low-molecular-weightnitrogen-containing compounds in blood - Google Patents

Food for improving clinical conditions capable of lowering the concentration of low-molecular-weightnitrogen-containing compounds in blood

Info

Publication number
HK1091129A1
HK1091129A1 HK06111794A HK06111794A HK1091129A1 HK 1091129 A1 HK1091129 A1 HK 1091129A1 HK 06111794 A HK06111794 A HK 06111794A HK 06111794 A HK06111794 A HK 06111794A HK 1091129 A1 HK1091129 A1 HK 1091129A1
Authority
HK
Hong Kong
Prior art keywords
weightnitrogen
lowering
blood
food
molecular
Prior art date
Application number
HK06111794A
Other languages
English (en)
Inventor
Yasumi Yugari
Takaaki Kobayashi
Shu Furuya
Original Assignee
Cheiron Japan Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cheiron Japan Co filed Critical Cheiron Japan Co
Publication of HK1091129A1 publication Critical patent/HK1091129A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK06111794A 2003-03-26 2006-10-25 Food for improving clinical conditions capable of lowering the concentration of low-molecular-weightnitrogen-containing compounds in blood HK1091129A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003086141 2003-03-26
PCT/JP2004/004319 WO2004084919A1 (ja) 2003-03-26 2004-03-26 血中低分子量含窒素化合物の濃度を低減させる病態改善用食品

Publications (1)

Publication Number Publication Date
HK1091129A1 true HK1091129A1 (en) 2007-01-12

Family

ID=33095050

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06111794A HK1091129A1 (en) 2003-03-26 2006-10-25 Food for improving clinical conditions capable of lowering the concentration of low-molecular-weightnitrogen-containing compounds in blood

Country Status (9)

Country Link
US (1) US20060210606A1 (xx)
EP (1) EP1616570A4 (xx)
JP (1) JPWO2004084919A1 (xx)
KR (1) KR100787554B1 (xx)
CN (1) CN100372541C (xx)
BR (1) BRPI0408698A (xx)
CA (1) CA2519761A1 (xx)
HK (1) HK1091129A1 (xx)
WO (1) WO2004084919A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100679750B1 (ko) * 2005-09-14 2007-02-06 김진만 인체체취저감용 보조식품조성물
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8993039B2 (en) 2006-01-25 2015-03-31 Tate & Lyle Ingredients Americas Llc Fiber-containing carbohydrate composition
US8057840B2 (en) * 2006-01-25 2011-11-15 Tate & Lyle Ingredients Americas Llc Food products comprising a slowly digestible or digestion resistant carbohydrate composition
KR101015115B1 (ko) * 2006-07-28 2011-02-16 대상 주식회사 키토산과 알긴산을 포함하는 기능성 당면
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
WO2011046768A2 (en) * 2009-10-12 2011-04-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Masking bitter flavors
WO2021043382A1 (en) * 2019-09-05 2021-03-11 Hesen Sherif Salah Abdulaziz Novel biological enteric dialysis method for ckd and esrd
US11540549B2 (en) 2019-11-28 2023-01-03 Tate & Lyle Solutions Usa Llc High-fiber, low-sugar soluble dietary fibers, products including them and methods for using them

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS574922A (en) * 1980-06-12 1982-01-11 Yakult Honsha Co Ltd Agent for lowering ammonia in blood
EP0276273A1 (en) * 1986-08-02 1988-08-03 FISONS plc Use of certain polysaccharides for the treatment of hepatic or renal failure
JPH07121867B2 (ja) * 1986-11-27 1995-12-25 日本食品化工株式会社 肝機能活性化剤
JPH0622725B2 (ja) 1987-01-12 1994-03-30 株式会社日立製作所 圧延機の制御方法
WO1988008257A1 (en) * 1987-04-25 1988-11-03 Terumo Kabushiki Kaisha Food facilitating bowel movement
JP2779963B2 (ja) * 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
US5200218A (en) * 1989-11-08 1993-04-06 Lasater Priscilla D Composition for dog food
CA2053933C (en) * 1990-10-24 2002-09-10 Norman A. Greenberg Nutritional composition comprising hydrolysed soluble fiber
JP2978332B2 (ja) * 1992-05-11 1999-11-15 日本化薬株式会社 腸内代謝改善食品および腸内代謝改善剤
JP3602551B2 (ja) * 1993-03-02 2004-12-15 太陽化学株式会社 肝機能障害改善及び予防組成物
JPH10194975A (ja) * 1997-01-10 1998-07-28 Morinaga Milk Ind Co Ltd 肝疾患治療剤
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
JP2000169376A (ja) * 1998-12-10 2000-06-20 Suntory Ltd 高アンモニア血症治療剤
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
JP2002281921A (ja) * 2001-03-28 2002-10-02 Yaizu Suisankagaku Industry Co Ltd 低蛋白澱粉食品

Also Published As

Publication number Publication date
CA2519761A1 (en) 2004-10-07
WO2004084919A1 (ja) 2004-10-07
EP1616570A1 (en) 2006-01-18
US20060210606A1 (en) 2006-09-21
EP1616570A4 (en) 2009-08-12
CN1764463A (zh) 2006-04-26
CN100372541C (zh) 2008-03-05
JPWO2004084919A1 (ja) 2006-06-29
BRPI0408698A (pt) 2006-03-28
KR20060024766A (ko) 2006-03-17
KR100787554B1 (ko) 2007-12-21

Similar Documents

Publication Publication Date Title
HK1091129A1 (en) Food for improving clinical conditions capable of lowering the concentration of low-molecular-weightnitrogen-containing compounds in blood
EP1673138A4 (en) CONTROL OF GLUCOSE LEVEL IN BLOOD
TWI365045B (en) Use of infant formula with reduced protein content
HK1108134A1 (en) Methods for the inactivation of microorganisms in biological fluids
EP1552269A4 (en) FORMOL-AMMONIUM SALT COMPLEXES FOR STABILIZING GLOBULES
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
SG118408A1 (en) Methods of monitoring the concentration of an analyte
EP1774029A4 (en) METHOD FOR DETECTING THE RISKS OF NON-INSULIN-DEPENDENT DIABETES AND FOR TREATING THIS TYPE OF DIABETES
PL377552A1 (pl) Leczenie zespołu nadpobudliwości psychoruchowej z deficytem uwagi
ZA200510282B (en) Compositions and methods for the diagnosis and treatment of tumor
PL377464A1 (pl) Aminoalkoksyindole jako ligandy receptora 5-HT6 do leczenia zaburzeń OUN
EP1750698A4 (en) 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
GB2442365B (en) Methods of determining compounds useful in the treatment of bipolar disorders
IL180199A0 (en) Process for improvement of virus- safe biological fluids
AU2003283987A8 (en) Method for facilitating blood vessel hemostasis
AU2003237792A8 (en) Compositions and methods for the diagnosis and treatment of tumor
EP1603467A4 (en) BLOOD VESSEL-COLLECTING DEVICE
EP1720410A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND CLINICAL REMOVAL OF PSORIASIS
GB0415181D0 (en) Compounds for use in the treatment of infection
PL1638591T3 (pl) Agoniści SLRP klasy III do stosowania w ograniczeniu tworzenia naczyń krwionośnych
ZA200604365B (en) Compositions and methods for the diagnosis and treatment of tumor
AU2003228787A8 (en) Composition and method for reducing post-prandial blood glucose
AU2003297912A8 (en) Methods for screening compounds for use in the treatment of disease
GB0312844D0 (en) Use of compounds in medicine
ZA200608015B (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190326